Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company 13therapeutics Inc.
DescriptionPro-inflammatory cytokine inhibitor
Molecular Target Toll-like receptor 3 (TLR3) ; Toll-like receptor 4 (TLR4)
Mechanism of ActionToll-like receptor 4 (TLR4) inhibitor
Therapeutic ModalityPeptide
Latest Stage of DevelopmentDiscovery
Standard Indication Pulmonary (unspecified)
Indication DetailsTreat pulmonary inflammation
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today